Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Verismo Therapeutics
Seagen Inc.
Novartis
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Numab Therapeutics AG
Ascentage Pharma Group Inc.
University of Pennsylvania
Sotio Biotech Inc.
Aromics Therapeutics
NGM Biopharmaceuticals, Inc
UTC Therapeutics Inc.
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Multitude Therapeutics Inc.
Candel Therapeutics, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Augusta University
AbbVie
AbbVie
MacroGenics
Incyte Corporation
Incyte Corporation
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Chinese PLA General Hospital
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Morphotek
University of Chicago
Astellas Pharma Inc
Anza Therapeutics, Inc.